John C.M. Farquhar Sells 27,230 Shares of Heartflow (NASDAQ:HTFL) Stock

Heartflow, Inc. (NASDAQ:HTFL) CEO John C.M. Farquhar sold 27,230 shares of the company’s stock in a transaction that occurred on Friday, August 21st. The shares were sold at an average price of $50.00, for a total value of $1,361,500.00. Following the sale, the chief executive officer directly owned 360,814 shares in the company, valued at approximately $18,040,700. This represents a 7.02% decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is accessible through this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan.

John C.M. Farquhar also recently made the following trade(s):

• On Tuesday, August 18th, John C.M. Farquhar sold 32,676 shares of Heartflow stock. The stock was sold at an average price of $45.00, for a total transaction of $1,470,420.00.
• On Friday, August 14th, John C.M. Farquhar sold 15,560 shares of Heartflow stock. The shares were sold at an average price of $39.06, for a total transaction of $607,773.60.
• On Monday, August 10th, John C.M. Farquhar sold 22,562 shares of Heartflow stock. The stock was sold at an average price of $28.31, for a total value of $638,730.22.
• On Friday, July 10th, John C.M. Farquhar sold 22,562 shares of Heartflow stock. The stock was sold at an average price of $27.75, for a total transaction of $626,095.50.
• On Wednesday, June 24th, John C.M. Farquhar sold 38,900 shares of Heartflow stock. The stock was sold at an average price of $35.00, for a total transaction of $1,361,500.00.
• On Wednesday, June 10th, John C.M. Farquhar sold 22,562 shares of Heartflow stock. The shares were sold at an average price of $28.50, for a total transaction of $643,017.00.

Heartflow Stock Performance

Shares of HTFL traded down $0.31 during mid-day trading on Tuesday, reaching $49.89. 1,748,540 shares of the company’s stock traded hands, compared to its average volume of 1,534,533. The business’s 50-day moving average price is $31.00 and its 200-day moving average price is $28.47. The stock has a market capitalization of $4.34 billion and a P/E ratio of -27.26. Heartflow, Inc. has a 12 month low of $20.13 and a 12 month high of $51.19.

Heartflow (NASDAQ:HTFL) last posted its earnings results on Thursday, August 13th. The company reported ($0.07) EPS for the quarter, beating the consensus estimate of ($0.22) by $0.15. Heartflow had a negative return on equity of 23.52% and a negative net margin of 55.82%.The firm had revenue of $64.08 million for the quarter. The business’s quarterly revenue was up 47.7% on a year-over-year basis. Equities research analysts anticipate that Heartflow, Inc. will post -0.82 EPS for the current year.

Institutional Inflows and Outflows

Several institutional investors have recently modified their holdings of the stock. XXEC Inc. purchased a new position in shares of Heartflow in the second quarter worth approximately $2,524,764,000. Sei Investments Co. boosted its stake in Heartflow by 342.5% in the 1st quarter. Sei Investments Co. now owns 67,048 shares of the company’s stock worth $1,631,000 after purchasing an additional 51,895 shares during the period. Quantinno Capital Management LP purchased a new position in Heartflow during the 1st quarter worth approximately $1,734,000. Handelsbanken Fonder AB purchased a new stake in shares of Heartflow in the second quarter valued at $910,000. Finally, Walleye Capital LLC acquired a new stake in shares of Heartflow in the second quarter worth $8,760,000.

Analyst Ratings Changes

A number of brokerages recently issued reports on HTFL. Canaccord Genuity Group increased their target price on shares of Heartflow from $37.00 to $45.00 and gave the company a “buy” rating in a research report on Friday, August 14th. Freedom Capital upgraded shares of Heartflow to a “strong-buy” rating in a research report on Tuesday, June 30th. JPMorgan Chase & Co. raised their price objective on shares of Heartflow from $35.00 to $45.00 and gave the company an “overweight” rating in a research note on Friday, August 14th. Robert W. Baird set a $45.00 target price on Heartflow in a research report on Friday, August 14th. Finally, Benchmark restated a “buy” rating on shares of Heartflow in a report on Friday, August 14th. One research analyst has rated the stock with a Strong Buy rating, eight have assigned a Buy rating, two have assigned a Hold rating and one has given a Sell rating to the company’s stock. According to data from MarketBeat, the stock presently has an average rating of “Moderate Buy” and a consensus target price of $43.43.

About Heartflow

HeartFlow, Inc (NASDAQ: HTFL) is a medical technology company that develops non-invasive diagnostic solutions for coronary artery disease. The company’s core offering translates coronary CT angiography (CTA) data into a patient-specific, three-dimensional physiological model of the coronary arteries. Using advanced image processing and computational modeling, HeartFlow’s analysis estimates fractional flow reserve (FFR) values throughout the coronary tree to identify ischemia-producing lesions without the need for invasive pressure-wire measurements.

HeartFlow’s cloud-based service integrates with clinical workflows: clinicians submit coronary CTA images and receive a detailed, color-coded 3D map and report that highlights lesion-specific FFR values and physiological impact.